In a specific subset of CRCs, there is an upregulation of various class I HDACs, such as HDAC1 in 36.4% of cases, HDAC2 in 57.9%, and HDAC3 in 72.9% of CRC specimens. This evidence concerns the gene HDAC2 and colorectal carcinoma.